Aaron Wightman1, Miranda C Bradford, Jordan Symons, Thomas V Brogan. 1. 1Division of Nephrology, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI. 2Children's Core for Biomedical Statistics, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA. 3Division of Nephrology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA. 4Division of Nephrology, Seattle Children's Hospital, Seattle, WA. 5Division of Pediatric Critical Care, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA. 6Division of Critical Care, Seattle Children's Hospital, Seattle, WA.
Abstract
OBJECTIVE: To investigate the prevalence and survival to discharge of neonates with kidney disease who received extracorporeal life support. DESIGN: We analyzed the Extracorporeal Life Support Organization international registry of neonates (< 30 d old) who received extracorporeal life support from 1989 to 2012. We used International Classification of Diseases and Related Health Problems, 9th Revision, Clinical Modification, codes to identify neonates with kidney disease at time of cannulation for extracorporeal life support. SETTING: Participating Extracorporeal Life Support Organization centers. PATIENTS: All neonates who received extracorporeal life support at an Extracorporeal Life Support Organization center from 1989 to 2012. INTERVENTIONS: We performed bivariate logistic regression to estimate associations between survival and covariates. We used unadjusted and adjusted logistic regression to compare survival to discharge between neonates with and without kidney disease. Odds ratios were estimated separately for three groups based on extracorporeal life support indication: pulmonary indication without congenital diaphragmatic hernia, pulmonary indication with congenital diaphragmatic hernia, and cardiac indication. Adjusted models included covariates identified as significant in bivariate models for each group. MEASUREMENTS AND MAIN RESULTS: The primary outcome measure was survival to discharge from hospitalization. Of the 28,755 neonates who received extracorporeal life support, 405 had kidney disease (extracorporeal life support indication: 210 pulmonary indication without congenital diaphragmatic hernia, 65 pulmonary indication with congenital diaphragmatic hernia, and 130 cardiac indication). Survival was lower in neonates with kidney disease than those without (49% vs 82% pulmonary indication without congenital diaphragmatic hernia, 25% vs 51% pulmonary indication with congenital diaphragmatic hernia, 21% vs 41% cardiac indication). Kidney disease was associated with reduced survival in adjusted models (95% CI for odds ratio 0.31-0.59 pulmonary indication without congenital diaphragmatic hernia, 0.27-0.89 pulmonary indication with congenital diaphragmatic hernia, 0.31-0.77 cardiac indication). CONCLUSIONS: Neonates with kidney disease who receive extracorporeal life support have poorer survival to discharge compared with other neonates who receive extracorporeal life support, suggesting that kidney disease should be considered when making extracorporeal life support initiation decisions.
OBJECTIVE: To investigate the prevalence and survival to discharge of neonates with kidney disease who received extracorporeal life support. DESIGN: We analyzed the Extracorporeal Life Support Organization international registry of neonates (< 30 d old) who received extracorporeal life support from 1989 to 2012. We used International Classification of Diseases and Related Health Problems, 9th Revision, Clinical Modification, codes to identify neonates with kidney disease at time of cannulation for extracorporeal life support. SETTING: Participating Extracorporeal Life Support Organization centers. PATIENTS: All neonates who received extracorporeal life support at an Extracorporeal Life Support Organization center from 1989 to 2012. INTERVENTIONS: We performed bivariate logistic regression to estimate associations between survival and covariates. We used unadjusted and adjusted logistic regression to compare survival to discharge between neonates with and without kidney disease. Odds ratios were estimated separately for three groups based on extracorporeal life support indication: pulmonary indication without congenital diaphragmatic hernia, pulmonary indication with congenital diaphragmatic hernia, and cardiac indication. Adjusted models included covariates identified as significant in bivariate models for each group. MEASUREMENTS AND MAIN RESULTS: The primary outcome measure was survival to discharge from hospitalization. Of the 28,755 neonates who received extracorporeal life support, 405 had kidney disease (extracorporeal life support indication: 210 pulmonary indication without congenital diaphragmatic hernia, 65 pulmonary indication with congenital diaphragmatic hernia, and 130 cardiac indication). Survival was lower in neonates with kidney disease than those without (49% vs 82% pulmonary indication without congenital diaphragmatic hernia, 25% vs 51% pulmonary indication with congenital diaphragmatic hernia, 21% vs 41% cardiac indication). Kidney disease was associated with reduced survival in adjusted models (95% CI for odds ratio 0.31-0.59 pulmonary indication without congenital diaphragmatic hernia, 0.27-0.89 pulmonary indication with congenital diaphragmatic hernia, 0.31-0.77 cardiac indication). CONCLUSIONS: Neonates with kidney disease who receive extracorporeal life support have poorer survival to discharge compared with other neonates who receive extracorporeal life support, suggesting that kidney disease should be considered when making extracorporeal life support initiation decisions.
Authors: Jeffrey Shuhaiber; Ravi R Thiagarajan; Peter C Laussen; Francis Fynn-Thompson; Pedro del Nido; Frank Pigula Journal: Ann Thorac Surg Date: 2011-04-22 Impact factor: 4.330
Authors: Ravindranath Tiruvoipati; Yana Vinogradova; Gail Faulkner; Andrzej W Sosnowski; Richard K Firmin; Giles J Peek Journal: J Pediatr Surg Date: 2007-08 Impact factor: 2.545
Authors: Robyn J. Meyer; Patrick D. Brophy; Timothy E. Bunchman; Gail M. Annich; Norma J. Maxvold; Theresa A. Mottes; Joseph R. Custer Journal: Pediatr Crit Care Med Date: 2001-07 Impact factor: 3.624
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Alexander Assmann; Andreas Beckmann; Christof Schmid; Karl Werdan; Guido Michels; Oliver Miera; Florian Schmidt; Stefan Klotz; Christoph Starck; Kevin Pilarczyk; Ardawan Rastan; Marion Burckhardt; Monika Nothacker; Ralf Muellenbach; York Zausig; Nils Haake; Heinrich Groesdonk; Markus Ferrari; Michael Buerke; Marcus Hennersdorf; Mark Rosenberg; Thomas Schaible; Harald Köditz; Stefan Kluge; Uwe Janssens; Matthias Lubnow; Andreas Flemmer; Susanne Herber-Jonat; Lucas Wessel; Dirk Buchwald; Sven Maier; Lars Krüger; Andreas Fründ; Rolf Jaksties; Stefan Fischer; Karsten Wiebe; Christiane S Hartog; Omer Dzemali; Daniel Zimpfer; Elfriede Ruttmann-Ulmer; Christian Schlensak; Malte Kelm; Stephan Ensminger; Udo Boeken Journal: ESC Heart Fail Date: 2021-11-22